Oncology PracticeCirculating tumor DNA identified by fragment sizeNovember 7, 2018Gynecologic CancerGenitourinary CancerBreast CancerRenal Cell CarcinomaCNS/Brain CancerMelanoma
Oncology PracticeFDA approves second pegfilgrastim biosimilarNovember 2, 2018Patient & Survivor CareBreast Cancer
Oncology PracticeBreast cancer in men comparable with women, gonadal therapy debatedOctober 23, 2018Breast Cancer
Oncology PracticeHDAC/aromatase inhibitor combo shows promise for HR+/HER2- advanced breast cancerOctober 21, 2018Breast Cancer
Oncology PracticePALOMA-3: Overall survival better for endocrine-sensitive patients onlyOctober 21, 2018Breast Cancer
Oncology PracticeFinally, immunotherapy shows benefit in TNBCOctober 21, 2018Breast CancerImmuno-oncology
Oncology PracticeGenotype-driven dosing reduces 5-FU, capecitabine toxicityOctober 20, 2018GastroenterologyBreast CancerGastrointestinal Cancer
Oncology PracticeTalazoparib approved for HER2-negative advanced breast cancerOctober 16, 2018Breast Cancer
Oncology PracticeTech-based cancer company raises access concernsOctober 12, 2018Practice ManagementPatient & Survivor CareBreast CancerGynecologic CancerBusiness of Medicine
Oncology PracticeESMO 2018 to highlight research on advanced breast cancerOctober 8, 2018Breast Cancer
Oncology PracticeMBC care causes more money problems for uninsured – but more financial stress for the insuredOctober 4, 2018Breast CancerPatient & Survivor CarePractice ManagementBusiness of Medicine
Oncology PracticeInvestigators identify 21 genomic “hotspots” in breast cancersOctober 3, 2018Breast Cancer
